Press monitoring
Secret Weapon of Retroviruses That Cause Cancer
3.3.2010 | Press monitoring
Oncogenic retroviruses are a particular family of viruses that can cause some types of cancer. Thierry Heidmann and his colleagues in the CNRS-Institut Gustave Roussy-Université Paris Sud 11 "Rétrovirus endogènes et éléments rétroïdes des eucaryotes supérieurs" Laboratory have studied these viruses. They have identified a "virulence...
Skin Cells Turned into Brain Cells
24.2.2010 | Press monitoring
A simple approach shows that cells might be more flexible than once thought.
How bioelectrics research could make us healthier
17.2.2010 | Press monitoring
Imagine a technology that, in a few controlled zaps, could cure cancer, purify water, boost alternative-energy production and wrangle agricultural pests — without harmful side effects for humans.
Microbes produce fuels directly from biomass
10.2.2010 | Press monitoring
A collaboration led by researchers with the U.S. Department of Energy's Joint BioEnergy Institute (JBEI) has developed a microbe that can produce an advanced biofuel directly from biomass. Deploying the tools of synthetic biology, the JBEI researchers engineered a strain of Escherichia coli (E. coli) bacteria to produce biodiesel fuel and other...
Sleep with the Fishes
3.2.2010 | Press monitoring
There's a new guinea pig in the search for sleep-related drugs: the zebrafish. Researchers at Harvard University have developed a screening tool that tests the effects of thousands of compounds on zebrafish behavior in an effort to discover new pathways that govern sleep. The research, published this week in the journal Science, may result in new...
Deadly Scorpion Provides Safe Pesticide
27.1.2010 | Press monitoring
Scorpions deliver a powerful, paralyzing venom -- a complex cocktail of poisonous peptides -- that immobilize animal prey on the spot. Some of the toxins in this cocktail damage only insects, which is why a Tel Aviv University researcher is harnessing them to create a safe and ecologically sound pesticide.
Lecithin nanoparticles show promise as vaccine adjuvant
20.1.2010 | Press monitoring
A team at Oregon State University has developed a new adjuvant, a substance that can increased the immune response when used in combination with a vaccine, based on lecithin nanoparticles. Currently only one adjuvant, aluminium hydroxide (alum), is approved for human use in the US because of safety concerns and is comparatively weak as well as...
Artificial Red Blood Cells for Drug Delivery
13.1.2010 | Press monitoring
In research published in the Proceedings of the National Academy of Sciences, a group specializing in drug delivery has found a way to create biodegradable, biocompatible particles with the size, shape, and flexibility of red blood cells. The group believes these artificial cells might be particularly effective not just for carrying oxygen but...
Researchers develop 'nano cocktail' to target and kill tumors
6.1.2010 | Press monitoring
A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.
New Insights Into Mushroom-Derived Drug Promising for Cancer Treatment
30.12.2009 | Press monitoring
A promising cancer drug, first discovered in a mushroom commonly used in Chinese medicine, could be made more effective thanks to researchers who have discovered how the drug works. The research is funded by the Biotechnology and Biological Sciences Research Council and was carried out at The University of Nottingham.
